In last trading session, Pulmonx Corp (NASDAQ:LUNG) saw 0.43 million shares changing hands with its beta currently measuring 0.47. Company’s recent per share price level of $2.6 trading at $0.01 or 0.39% at ring of the bell on the day assigns it a market valuation of $104.67M. That closing price of LUNG’s stock is at a discount of -260.38% from its 52-week high price of $9.37 and is indicating a premium of 3.85% from its 52-week low price of $2.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.28 million shares which gives us an average trading volume of 382.56K if we extend that period to 3-months.
For Pulmonx Corp (LUNG), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.57. Splitting up the data highlights that, out of 4 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Pulmonx Corp (NASDAQ:LUNG) trade information
Upright in the green during last session for gaining 0.39%, in the last five days LUNG remained trading in the red while hitting it’s week-highest on Tuesday, 06/24/25 when the stock touched $2.6 price level, adding 7.14% to its value on the day. Pulmonx Corp’s shares saw a change of -57.02% in year-to-date performance and have moved -0.76% in past 5-day. Pulmonx Corp (NASDAQ:LUNG) showed a performance of -12.16% in past 30-days. Number of shares sold short was 1.42 million shares which calculate 3.78 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 10 to the stock, which implies a rise of 74.0% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would drop -130.77% in reaching the projected high whereas dropping to the targeted low would mean a loss of -130.77% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -19.80% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -6.92% while estimates for its earnings growth in next 5 years are of 10.76%.
Pulmonx Corp (NASDAQ:LUNG)’s Major holders
Insiders are in possession of 4.40% of company’s total shares while institution are holding 93.34 percent of that, with stock having share float percentage of 97.64%. Investors also watch the number of corporate investors in a company very closely, which is 93.34% institutions for Pulmonx Corp that are currently holding shares of the company. PRIMECAP MANAGEMENT CO/CA/ is the top institutional holder at LUNG for having 5.71 million shares of worth $36.2 million. And as of 2024-06-30, it was holding 14.6622 of the company’s outstanding shares.
The second largest institutional holder is FMR LLC, which was holding about 5.28 million shares on 2024-06-30. The number of shares represents firm’s hold over 13.5609 of outstanding shares, having a total worth of $33.48 million.
